Outcomes of Ixazomib Treatment in Relapsed and Refractory Multiple Myeloma: Insights from Croatian Cooperative Group for Hematologic Diseases (KROHEM).
Batinić J, Dreta B, Rinčić G, Mrdeža A, Jakobac KM, Krišto DR, Vujčić M, Piršić M, Jonjić Ž, Periša V, Sinčić Petričević J, Coha B, Holik H, Valković T, Stanić M, Krečak I, Stojanović A, Sajfert D, Bašić-Kinda S.
Batinić J, et al. Among authors: dreta b.
Medicina (Kaunas). 2024 Nov 20;60(11):1905. doi: 10.3390/medicina60111905.
Medicina (Kaunas). 2024.
PMID: 39597090
Free PMC article.